Hyperfine Business Summary

Hyperfine, Inc. (HYPR) operates a medical technology business model centered on the commercialization of the Swoop® Portable MR Imaging® system, the first FDA-cleared portable, ultra-low-field MRI device. The company generates revenue through a "razor-and-blade" strategy, combining high-value capital equipment sales with recurring revenue streams from service contracts and advanced software subscriptions, specifically its Optive AI™ image enhancement platform. Business operations are segmented into hospital-based acute care (ICUs and emergency departments) and the rapidly expanding neurology office market, supported by 2024 IAC standards that facilitate CMS reimbursement for office-based scans. Hyperfine competes in a landscape dominated by traditional high-field MRI incumbents like GE HealthCare, Siemens Healthineers, and Philips, yet it distinguishes itself as a disruptive, point-of-care alternative that eliminates the infrastructure requirements and high costs associated with conventional fixed MRI suites. The company was founded by Dr. Jonathan Rothberg, a prolific serial entrepreneur and National Medal of Technology and Innovation recipient known for founding 4Catalyzer and Ion Torrent. The leadership team is currently headed by President and CEO Maria Sainz, who brings over 20 years of medtech experience from roles at AEGEA Medical and Guidant Corporation. Key executives include Chief Administrative and Financial Officer Brett Hale, Chief Operating Officer Dr. Thomas Teisseyre, and Vice President of Technology Dr. Rafael O’Halloran, who leads the AI-driven imaging pipeline. Hyperfine is backed by a sophisticated investor base that includes Alphabet Inc., Vanguard Group, and BlackRock, and its board features seasoned industry veterans such as Independent Chairperson Daniel Wolterman and Director John Dahldorf.